Chen JQ, Zheng M, Yin WH, Wang P, et al. Safety and efficacy of the selective TYK2/JAK1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: A phase 1b, randomized, double-blind, placebo-controlled study. Br J Dermatol 2025 May 14:ljaf185. doi: 10.1093.
PMID: 40367132